Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 8 (3), 227-239
- https://doi.org/10.1016/j.ccr.2005.08.003
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Stochasticity in gene expression: from theories to phenotypesNature Reviews Genetics, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrenceCancer, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast CancerJournal of Clinical Oncology, 2003
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- The Hallmarks of CancerCell, 2000